Menadex

Dexketoprofen, the active ingredient in Menadex, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an injectable solution for intramuscular and intravenous use. It provides analgesic and anti‑inflammatory effects for moderate acute pain, postoperative pain, musculoskeletal pain and dental pain in adult patients.

GNH USA supplies Menadex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution. Customers benefit from reliable logistics, temperature‑controlled shipping where required, and responsive technical support.

Dexketoprofen is an NSAID that reduces pain and inflammation in several acute pain settings.

Moderate acute pain: provides rapid analgesia for sudden, severe pain episodes. Postoperative pain: helps control pain after surgical procedures. Musculoskeletal pain: alleviates pain associated with strains, sprains and injuries. Dental pain: reduces pain following dental extractions or procedures.

Dexketoprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea or mild gastrointestinal discomfort. - Headache or dizziness. - Injection‑site pain or erythema. - Transient increase in blood pressure. - Mild renal function changes. - Fatigue or somnolence.

Serious or Rare Side Effects: - Severe gastrointestinal bleeding or ulcer perforation. - Acute renal impairment or failure. - Hypersensitivity reactions including anaphylaxis or Stevens‑Johnson syndrome. - Hepatic dysfunction or elevated liver enzymes. - Cardiovascular events such as myocardial infarction or stroke. - Hematologic abnormalities like thrombocytopenia.

When prescribing Menadex, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

Renal function: assess baseline kidney function and monitor during therapy. Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent myocardial infarction. Gastrointestinal history: use with caution in patients with ulcer disease or bleeding. Concomitant anticoagulants: monitor for increased bleeding risk. Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Dexketoprofen can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: may reduce renal function. - Lithium: NSAIDs can increase lithium levels. - Methotrexate: reduced clearance may cause toxicity.